9/13/2024 11:53:56 AM - This Switzerland-based Medical Products firm reported Jun '24 quarterly earnings +7% on +3% sales revenues versus the year ago period. Prior earnings history (C criteria) is not a match with the fundamental guidelines of the fact-based investment system.
Consolidating above its 200 DMA line. Last noted with caution in the 2/17/22 mid-day report - "This Switzerland-based Medical Products firm showed greatly improved results in the Jun, Sep, and Dec '21 quarters versus the year ago periods. Prior earnings history (C and A criteria) is not a match with the fundamental guidelines of the fact-based investment system."
Pulled back from its all-time high and recently found support near its 200 DMA line but met resistance at its 50 DMA line when rebounding. This Switzerland-based Medical Products firm showed greatly improved results in the Jun, Sep, and Dec '21 quarters versus the year ago periods. Prior earnings history (C and A criteria) is not a match with the fundamental guidelines of the fact-based investment system.
Pulled back from its all-time high and recently found support near its 200 DMA line. This Switzerland-based Medical Products firm showed greatly improved results in the Jun, Sep, and Dec '21 quarters versus the year ago periods. Prior earnings history (C and A criteria) is not a match with the fundamental guidelines of the fact-based investment system.
Hovering near its all-time high. Prior mid-day reports noted - "This Switzerland-based Medical Products firm showed better results in the Jun and Sep '21 quarters, but its prior earnings history (C and A criteria) is below the guidelines of the fact-based investment system."
Hovering near its all-time high. Prior mid-day reports noted - "This Switzerland-based Medical Products firm showed better results in the Jun and Sep '21 quarters, but its prior earnings history (C and A criteria) is below the guidelines of the fact-based investment system."
Hovering near its all-time high making its 2nd consecutive mid-day report appearance. This Switzerland-based Medical Products firm showed better results in the Jun and Sep '21 quarters, but its prior earnings history (C and A criteria) is below the guidelines of the fact-based investment system.
Hovering near its all-time high. This Switzerland-based Medical Products firm showed better results in the Jun and Sep '21 quarters, but its prior earnings history (C and A criteria) is below the guidelines of the fact-based investment system.
Showed better results in the Jun and Sep '21 quarters but its prior earnings history (C and A criteria) is below the guidelines of the fact-based investment system.
Sales and earnings history below guidelines. Extended from any recent base, it hit another new 52-week high today.
Sales and earnings history below guidelines. Extended from any recent base, it hit another new 52-week high today.
Sales and earnings history below guidelines. Extended from any recent base.